Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844983 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC
A Phase 2 study, sponsored by Sirnaomics.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT04844983: Completed Phase 2 study, sponsored by Sirnaomics.
NCT04844983 is a Phase 2 study that has completed, run by Sirnaomics. The registered enrollment target is 44 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04844983, a Phase 2 study, has completed, sponsored by Sirnaomics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma (in situ) skin cancer (isSCC).
Primary Outcome
Proportion of participants with histological clearance of treated isSCC lesion at the End of Treatment (EOT).
Interventions
- DRUG STP705
- OTHER Placebo Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-05-18 |
| Est. Completion | 2022-12-06 |
| Phase | Phase 2 |
What the finished NCT04844983 record still lists
NCT04844983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which STP705 is the first listed.
NCT04844983 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04844983 about?
NCT04844983 is a clinical study titled "A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC". The purpose of this trial is to evaluate safety, tolerability and efficacy of various doses of STP705 administered as intralesional injection in subjects with cutaneous squamous cell carcinoma (in situ) skin cancer (isSCC).
What is the current status of trial NCT04844983?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2021-05-18. Estimated completion is 2022-12-06.
What interventions are being tested in trial NCT04844983?
The interventions under investigation include: STP705 (DRUG), Placebo Saline (OTHER).
Who is sponsoring clinical trial NCT04844983?
This trial is sponsored by Sirnaomics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04844983's enrollment target sits among peer trials
44 1322nd of 2000 higher than 669 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI